Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Australian deal done: Doctor Care Anywhere (ASX:DOC) share price up

The Doctor Care Anywhere Group PLC (ASX: DOC) share price is rising after it announced that it has entered the Australian market with an acquisition.

Doctor Care Anywhere is a UK based telehealth company. It is a doctor led company that provides a range of telehealth services through its proprietary platform.

Doctor Care Anywhere enters Australian market

The company announced that it has entered the Australian telehealth market with the acquisition of Australian based company GP2U Telehealth.

GP2U Telehealth provides telehealth GP services under the GP2U brand and virtual mental health services under the Psych2U brand. The Psych2U brand represents 78% of GP2U Telehealth’s total revenue and has a channel partnership with health insurer HCF.

Doctor Care Anywhere said that GP2U Telehealth grew unaudited gross revenue by 54.8% to $4.4 million for FY21. It grew consultations by psychiatrists, psychologists and GPs by 51.4% to 35,000 in FY21.

Management said that it sees significant opportunities to grow mental health and GP telehealth services in Australia, noting the growing mental health needs particularly in rural areas.

Doctor Care Anywhere CEO Dr Bayju Thakar said: “This acquisition represents another important milestone for Doctor Care Anywhere; giving us a platform on which to build our presence in the Australian market and further expand our international business.”

The financial details of the deal

Doctor Care Anywhere will acquire 100% of the shares in GP2U Telehealth for A$11 million, which is 2.5 times GP2U’s unaudited revenue for FY21.

Of the A$11 million, A$3.3 million will be funded by Doctor Care Anywhere’s existing cash reserves. The remaining $7.7 million to come from CDIs/new shares, with 10,555,173 CDIs issued to shareholders of GP2U at a price of $0.73 per CDI.

Doctor Care Anywhere noted that there are no material liabilities on GP2U Teleheath’s balance sheet.

Final thoughts on Doctor Care Anywhere and the share price

There seems to be good demand for digital health services with potential for lots of growth and Doctor Care Anywhere appears to be making moves to take advantage of that.

The Doctor Care Anywhere share price is up over 3% on the back of the news of the acquisition. The share price is down 14.5% since the December 2020 IPO.

With the trends that the pandemic has created and accelerated, I think Doctor Care Anywhere has stronger tailwinds than before COVID came along.

This could be one to watch if the trend of demand for digital health services continues beyond the new normal after COVID-19.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content